Member Info for Letitrun

Aqua when was the 1.4m amount sold? If it was following the news of pending suspension it would have been material change to their original position and outlook on their holding with not knowing how long suspension will last. I highly doubt they’ve been sneaky fooling everyone into selling a £100k odd worth of shares….

Also your comment on £900k extra costs, its just over £1m and isn’t a cash cost it’s an accounting cost from share based payments. I believe related to the options they repriced. They’re irrelevant to the underlying performance.

Good to see the FD buying up new shares bodes well for the year.

Good to see results out early for a change and looking more like the house is in order. Good sales & margin progress as we already knew from trading update. Some good snippets on Sweetbiotix coming through which is sounding very promising. I’m increasingly confident this stock is going to rerate aggressively and multi bag from here either later this year or 2027 with Sweet now seriously knocking on the commercial door.

Fried i just clicked the link in your post and takes me straight through to the opti site to Sign Up - do so at the top right and they will email you directly the email in my post earlier to register your interest

If already registered to OPti website you should have recieved an email from them today requesting you to register your attendance if intersted.

"OptiBiotix will be hosting an in-person shareholder event in London this June.

The event will provide an overview of first-generation products, second-generation products and their route to market and sampling of SweetBiotix.

To help us assess attendance numbers and venue requirements, please register your interest by clicking through to this announcement and liking the post (see photo below).

Once we have a gauge of numbers, further event information will follow."

Theres then a button to click below in the email.

Great to hear them come thorugh on this and aligns with what theyve been saying recently about progress on Sweet. I think they will be communicating to us through the Opti website about this so want you to 'sign up' and make a profile there.

Holding a face to face meeting with shareholders shows the bod certainly arnt hiding away pushing the can down the road - Looks like Sweet is actually coming this time - look forward to it along with the rerate :) GLA

Fried the RNS stated their plans to 'demonstrate' sweetbiotix to investors in H1. Im not sure how that is misleading if they do just that and show investors the product. It doesn't say to launch products in H1 and to say otherwise imo is a misleading interpretation of what was RNS'd which i often find happens with this stock. As to say we are where we were many years ago isn't an accurate statement considering they've recently resolved a major manufacturing issue which prevented the old Sweetbiotix from moving ahead to commercial. As a result of recent progress they've also improved the production cost by now being able to use sucrose (therefore its commercial viability) whilst also improving the the overall products taste and purity. I imagine they have a good idea of the taste of this new product prior to sharing with investors. The difference from many years ago is they now have an optimised approach to produce it and can actually get it to market. On the Q&A it mentions they will outline their approach to taking this to market shortly which would suggest they now have a path forward for the tech.

would you prefer they had Sweet on the market already that cost a fortune to produce, didn't taste as good and therefore wouldn't be able to pick up traction from partners, or, launch with an optimised cost efficient production process and better product which will stand it in a far better commercial position when it does come to market?

Along similar lines to my thoughts as the end product is a GOS / FOS but sweetened using this enzyme process.

Fried it has always been a sampling session in h1 for shareholders, I certainly wasn’t expecting a product launch but to be able to taste it and see it moves this exciting tech towards reality rather than just hope & dreams.

AS good points which I’m sure they will be more in tune with this than we are, particularly working with Firminech who are leaders in the field. From what I understand they are producing sweet fibres as GOS & FOS through a novel production technique. I’m not sure but it will depend on the structure of the final product and whether it could be classified as such which may circumvent such ‘novel’ regulations.

As for Croda can you share any big name brands that contain it? £7m is a big ask for first year revs of a new ingredient even for a co like Croda. No chance if you ask me.

Thanks Toyin, for the record I think the ceo here has got certain things wrong but has also done some good things such as the groundwork in recovering the business from going backwards. Currently it’s so far undervalue it offers great upside, especially with Sweet now making progress.

As for the investors net worth, it means nothing, only that if he loses his investment it won’t mean as much to him. The knowledge is that serious accounting issues forced the SBTX ceo out and now that stock is suspended pending outcome of an investigation on the rest of the business. Clearly the investor didn’t know that before buying at much higher levels and halving his investment as it stands …he won’t know what else may unravel, however time will tell and he may have other ideas for the business if he takes control. Currently it’s doesn’t look good and could go either way there.

Toyin I’m certainly not flustered but your post suggest you may be, which I apologise for.

You are correct Opti hasn’t launched sweet, yet they’ve delivered over £600k royalties from that product already (actually accounted and paid for).

Matrixyl has been around for decades, Zenkanine could get to that but won’t be anytime soon. Do you know how many products the ingredient would need to be in to generate £700k? Will take many years to build to that level.

On Axis you and Elrico shot down anyone who had alternative views to that product launch. I was one of those saying the numbers were crazy at the time.

The 25% shareholder was still buying at 20p+ and could have bought double the amount of shares he has now at today’s rates. He’s obviously in to deep, however he may have acquisition on his mind but still a mess he’s going to now pick up which he clearly did not foresee.

Also not to mention the massive dilution SBTX has had

Yes Lords, there’s a few SBTX disciples that even with the ceo here’s over optimistic approach on things over the years never did anything as shocking as the SBTX ceo did yet they all still followed into oblivion. Such as:

- put out a forecast of over £1m and from memory didn’t even deliver £100k

- launch of Axisbiotix was touted as being an immediate success of like 20k boxes a day or something stupid. Figures in the multi millions were being pushed. Toyin + Elrico was one of those who called anyone opposed to this an idiot (me at the time)

- royalties of an ingredient, of which a tiny amount is required in each product delivering £700k of royalties in 6 months of launch. This would require 100s of thousand if not millions of finished product to be sold already (hardly any Zenkanine products available yet)

I’m sure I could go on… then of course now the serious fraud.

The best result here is SBTX gets acquired and then whoever takes over builds it back. Either way it’s unlikely to rocket post suspension and more likely than not there will be more negative news which will take some time to recover. If it’s bad about the acquisitions then the company will be in serious trouble. No one however knows and anything until more facts come out is just speculation.

‘Enough said’ …all that video shows is an over optimistic ceo 2 years after ipo of a start up with a broad technology portfolio. In reality, and to be fair, they probably thought they could commercialise sweet far sooner, the ceo has even said it’s his biggest disappointment. They hit pretty serious technical issues which prevented them progressing. This is biotech and novel technology at that which they’re creating from scratch, things clearly aren’t easy. The main thing is they’ve now resolved the production enzyme issue which prevented them moving forward. If they are setting up a H1 event with the product that’s a big milestone so things are now moving again for this product and more tangible than anything previous.

A recent Q&A answer says they also intend to show investors how they will commercialise which to me says they now have a way forward to do so. ‘I will update on the progress withy the new enzyme and how we intend to take the product to market.’ You don’t pull shareholders together face to face if you don’t have something tangible to show them!

I also get the impression they are laser focused on Sweetbiotix and from what I have heard the ceo has now directly taken the reigns on pushing this product forward. To have a product available for H1 to show investors which is ‘all on track’ according to Opti Q&A suggests things are actually making good progress now.

Major production breakthrough with this new enzyme so 2026 could actually be a game changer for this company from these cheap levels.

Doubt that is the case to sign off accounts. As last year they had a liquid asset to support funds. Only thing different this year is SBTX suspension. The fact they can still trade it off market would be enough to satisfy the auditor anyhow so not sure that’s the case. If they were ‘desperate’ there is absolutely no chance they sell that much at the price they have in a suspended share with the CEO only recently fired for misstating significant revenue & profit figures.

Just the same old typical few on here who have sunk everything into SBTX from Opti and always have a negative narrative to push whenever theres anything to talk about here.

Fried i imagine they were approached for the stock otherwise if searching around they would have had to take much lower price to 9p. Topping up the cash whilst a stock asset you hold has just had its CEO fired for making up £700k of numbers fraudulently, is currently under investigation and has been suspended, provides a level of certainty to its own shareholders over funding. If everything is rosy at SBTX after this period they still have 5.7m shares to cash in future if SBTX recovers, its a balance of risk v's reward.

As for sweet I've recently seen on the opti website Q&A they have said everything is all proceeding as planned for H1.

Whilst you may be all in on SBTX no one knows what will happen. The facts we do know create massive uncertainty until resolved or otherwise.

Quite a sensible move to be honest no one knows what will come out of SBTX which I suspect will be more than just the royalty issue considering the length of time it is taking. IMO it doesn’t take 2 months just to check if a royalty is valid. The delay is even more concerning. Take some cash now whilst it’s a 50/50 gamble and still have some in the locker if SBTX does announce an all clear.

Optis growth is now similiar to that of PBX trajectory had it not been for the other CEO that came in here and more than halved sales. Since then the company has recovered growth which has been steady yoy and margins now improving nicely. Now they are reducing the variable costs by up to £500k+ as highlighted in the recent update and Sweetbiotix gets into gear this is a great opportunity for a multi bag from these levels. I also imagine many holders here sold down and ploughed it into SBTX when their ceo was selling the too good to be true dream.

Dire yet they continue to grow and have sales confirmed for 2026 already in January of over £800k so pretty nailed on for more growth this year with good and improving margins and large cost reductions. Clearly a few partners are coming to something. E-commerce was over £400k in 2024 which isn't included in the £800k or any orders received after the Jan release. They also have £100k royalty in H2 for SweetBiotix. On this basis alone they should on for £1.3-£1.5m for FY2026 already and anything else they receive in the next 8 months is more growth on top. Then the core business will look increasingly solid and will get very interesting when SweetBiotix launches.

This share seems to be constantly barraged with negative snipes by old holders. Just buy back in before the rerate from these levels and make some of your money back :)

Fried fully agree shareholders are forward looking so will depend on the loss and the pathway to the profitability, fully accept that. You do however have to look at the full picture. PBX & Opti subsidiaries were both on same revenue and EBITDA profitable in 2021, however when management changed it saw a 60% decline in revenue. Since then Opti has had to build back up, and has delivered steady growth every year since (not far off PBX's % growth trajectory). You are also right, the losses have increased and costs have gone up, however, this was from a conscious management decision to invest (in 2024 their marketing and selling costs were £651k alone). Yesterdays announcement showed they are continuing to grow sales AND making good progress on profitability with gross margins now building into a material gross profit and expected to improve from Q2. They are also making big reductions in investment now they have a satisfactory consumer base they can grow from more profitably. This to me shows a pathway to cash generation. On top of that, SweetBiotix manufacturing challenges have been resolved, surely this technology has future value considering a company has paid £100k every year with over a £500k+ total investment. Never Saw Croda pay SBTX a pre revenue royalty, maybe they value it more.. Therefore the core business with its improving outlook, Sweetbiotix technology finally sorting its manufacturing issues and its asset positions make the current valuation crazy.

On partners you can ask them through the website Q&A if you want specific comments on any. I've read one on Morepen who they advise the revenue went in to Opti accounts split between back end of 2024 and 2025. You can see these companies are still selling the products so they haven't left the building so not every single partner needs a mention. The big one in the USA is the no1 best selling weight loss company Hydroxcut which did get a mention...